Quince Therapeutics, Inc. (IRLA) Capital expenditures 2018–2025
Quince Therapeutics, Inc. (IRLA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$352,000FY2025 · since FY2018: $212,000 → $352,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $352,000 | +37.0% |
| FY2024 | $257,000 | +60.6% |
| FY2023 | $160,000 | +20.3% |
| FY2022 | $133,000 | -26.1% |
| FY2021 | $180,000 | +246.2% |
| FY2020 | $52,000 | -5.5% |
| FY2019 | $55,000 | -74.1% |
| FY2018 | $212,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice